Encouraging survival data from a phase I trial of radiation (RT) dose escalation with full dose gemcitabine (GEM) in patients with unresectable pancreatic cancer
C.J. McGinn, I. Shureiqi, J.M. Robertson, F.E. Eckhauser, D.C. Smith, D.A. Decker, K.H. Neumann, D. Brown, M. Strawderman, T.S. LawrenceVolume:
48
Year:
2000
Language:
english
DOI:
10.1016/s0360-3016(00)80240-0
File:
PDF, 116 KB
english, 2000